GLUE

Monte Rosa Therapeutics
GLUE

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$294.63M
EV
$-34.80M
Shares Outstanding
82.15M
Beta
1.53

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$16.13
P/E 2025E
-
P/Revenue 2025E
5.50x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Monte Rosa Therapeutics, Inc.

gainify
GLUE

Monte Rosa Therapeutics, Inc.

GLUE

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops MRT-2...

Sector

Healthcare

Industry

Biotechnology

CEO

Warmuth, Markus

Employees

134

IPO Date

2021-06-24

Headquarters

321 Harrison Avenue, Suite 900, Boston, Massachusetts, 02118, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved